Viromed Medical AG | WebDisclosure

PRESS RELEASE

published on 03/04/2026 at 07:44, 7 months 5 days ago

Viromed Medical AG signs letter of intent to acquire relyon plasma GmbH – Strategic step toward integrated platform for cold plasma technology
Viromed Medical AG signs letter of intent to acquire relyon plasma GmbH, a key strategic step towards an integrated platform for cold plasma technology. The acquisition aims to strengthen Viromed's technological position and expand its market presence

Acquisition Strategic Integration Viromed Medical AG Cold Plasma Technology Relyon Plasma GmbH
BRIEF

published on 03/03/2026 at 17:50, 7 months 6 days ago

Viromed Medical AG to Acquire relyon plasma GmbH

Medical Devices Mergers And Acquisitions Viromed Medical AG Cold Plasma Technology Relyon Plasma GmbH
BRIEF

published on 03/03/2026 at 17:50, 7 months 6 days ago

Viromed Medical AG va acquérir Relieon Plasma GmbH

Dispositifs Médicaux Fusions Et Acquisitions Viromed Medical AG Technologie Du Plasma Froid Relion Plasma GmbH
PRESS RELEASE

published on 03/03/2026 at 17:45, 7 months 6 days ago

EQS-Adhoc: Viromed Medical AG signs letter of intent to acquire relyon plasma GmbH
Viromed Medical AG signs letter of intent to acquire relyon plasma GmbH, expanding its value chain and gaining expertise in atmospheric plasma technology

Acquisition Letter Of Intent Plasma Technology Viromed Medical AG Relyon Plasma GmbH
BRIEF

published on 02/16/2026 at 10:19, 7 months 21 days ago

Viromed Medical AG fait progresser un traitement pulmonaire unique

Résistance Aux Antibiotiques Thérapie Par Plasma Froid Soins Intensifs Infections Pulmonaires Validation Préclinique
BRIEF

published on 02/16/2026 at 10:19, 7 months 21 days ago

Viromed Medical AG Advances with Unique Lung Treatment

Antibiotic Resistance Cold Plasma Therapy Intensive Care Lung Infections Preclinical Validation
PRESS RELEASE

published on 02/16/2026 at 10:14, 7 months 21 days ago

Viromed Medical AG: Globally unique preclinical data base – Saarland validation as key step toward first physical lung application
Viromed Medical AG presents globally unique preclinical data on cold plasma therapy for lung infections, with Saarland validation confirming a key step towards clinical application

Preclinical Data Viromed Medical AG Cold Plasma Therapy Lung Infections Saarland Validation
BRIEF

published on 01/27/2026 at 16:48, 8 months 13 days ago

MHH dévoilera ses recherches sur la thérapie par plasma froid pour les applications pulmonaires.

Innovation Médicale Résistance Aux Antibiotiques Viromed Medical AG Thérapie Par Plasma Froid Infections Pulmonaires
BRIEF

published on 01/27/2026 at 16:48, 8 months 13 days ago

MHH to Unveil Cold Plasma Therapy Research for Lung Applications

Medical Innovation Antibiotic Resistance Viromed Medical AG Cold Plasma Therapy Lung Infections
PRESS RELEASE

published on 01/27/2026 at 16:43, 8 months 13 days ago

MHH to Present Scientific Findings on Cold Plasma Therapy for Pulmonary Application at Press Conference in February 2026
MHH to present groundbreaking cold plasma therapy for pulmonary application at press conference in February 2026, addressing urgent clinical need worldwide

Scientific Findings Press Conference Viromed Medical AG Cold Plasma Therapy Pulmonary Application

Published on 10/09/2026 at 14:00, 7 hours 17 minutes ago

Stillwater Critical Minerals Upgrades to OTCQX Best Market, Expanding U.S. Market Presence
Published on 10/09/2026 at 14:00, 7 hours 17 minutes ago

Vogenx Appoints Board Member Richard Gorman as Chief Commercial Officer
Published on 10/09/2026 at 13:23, 7 hours 54 minutes ago

SLAM Exploration Announces Leadership Transition and Appointment of Jimmy Gravel as President and CEO
Published on 10/09/2026 at 13:00, 8 hours 17 minutes ago

Horizon Aircraft Reports Fiscal 2027 First Quarter Results and Advances Full-Scale Cavorite X7 Development
Published on 10/09/2026 at 13:00, 8 hours 17 minutes ago

Nepra Foods Launches Flagship PROPASTA Brand on Amazon

View all ACCESSWIRE

Published on 10/09/2026 at 19:22, 1 hour 55 minutes ago

EQS-Adhoc: elumeo SE switches financial reporting to comply with the German Commercial Code (HGB) and refines forecast for 2026
Published on 10/09/2026 at 19:14, 2 hours 3 minutes ago

Holding(s) in Company
Published on 10/09/2026 at 18:00, 3 hours 17 minutes ago

ARVERNE GROUP: Arverne franchit une étape majeure : l'Europe fait du projet Lithium de France un pilier de sa souveraineté industrielle
Published on 10/09/2026 at 18:00, 3 hours 17 minutes ago

ARVERNE GROUP: Arverne reaches a major milestone: Europe recognizes the Lithium de France Project as a pillar of its industrial sovereignty
Published on 10/09/2026 at 18:00, 3 hours 17 minutes ago

Private Equity Holding AG: Net Asset Value as of September 30, 2026

View all EQS

Published on 10/09/2026 at 19:27, 1 hour 49 minutes ago

Disclosure of transactions in own shares from October 1 to October 9, 2026
Published on 10/09/2026 at 19:27, 1 hour 49 minutes ago

Déclaration hebdomadaire d'opérations effectuées du 1er au 9 octobre 2026
Published on 10/09/2026 at 18:01, 3 hours 16 minutes ago

Titre de mon communiqué
Published on 10/09/2026 at 18:01, 3 hours 16 minutes ago

Title of my press release
Published on 10/09/2026 at 17:45, 3 hours 32 minutes ago

Déclaration des droits de vote à fin septembre 2026

View all LES ECHOS COMFI WIRE

News